Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ADVISORY, June 20, 2013 (GLOBE NEWSWIRE) -- What:PTC Therapeutics [PTCT], a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered small-molecule drugs that target post-transcriptional control processes, will visit the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO), which will occur today, June 20, on The NASDAQ Stock Market.
Help employers find you! Check out all the jobs and post your resume.
